Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ioanna Christopoulou"'
Autor:
Patrick Tjok Joe, Ioanna Christopoulou, Lien van Hoecke, Bert Schepens, Tine Ysenbaert, Carlo Heirman, Kris Thielemans, Xavier Saelens, Joeri L. Aerts
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Abstract Background Current human influenza vaccines lack the adaptability to match the mutational rate of the virus and therefore require annual revisions. Because of extensive manufacturing times and the possibility that antigenic alterations occur
Externí odkaz:
https://doaj.org/article/c946bfff7a2147e0912ce56ac5b126eb
Publikováno v:
Vaccines, Vol 7, Iss 3, p 113 (2019)
Background: Influenza virus infection predisposes to secondary bacterial pneumonia. Currently licensed influenza vaccines aim at the induction of neutralizing antibodies and are less effective if the induction of neutralizing antibodies is low and/or
Externí odkaz:
https://doaj.org/article/1303de7f93ca48969c1367b2fd70f510
Autor:
Tine Ysenbaert, Tod Strugnell, Harold Kleanthous, Thorsten U. Vogel, Raymond P. Oomen, Ioanna Christopoulou, Xavier Saelens, Emma R. Job, Anouk Smet, Eliud O. Oloo
Publikováno v:
npj Vaccines, Vol 3, Iss 1, Pp 1-11 (2018)
NPJ Vaccines
NPJ Vaccines
Split inactivated influenza vaccines remain one of the primary preventative strategies against severe influenza disease in the population. However, current vaccines are only effective against a limited number of matched strains. The need for broadly
Autor:
Joeri L. Aerts, Carlo Heirman, Patrick Tjok Joe, Xavier Saelens, Kris Thielemans, Lien Van Hoecke, Tine Ysenbaert, Ioanna Christopoulou, Bert Schepens
Publikováno v:
JOURNAL OF TRANSLATIONAL MEDICINE
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-14 (2019)
Journal of Translational Medicine
Background Current human influenza vaccines lack the adaptability to match the mutational rate of the virus and therefore require annual revisions. Because of extensive manufacturing times and the possibility that antigenic alterations occur during v
Autor:
Paco Hulpiau, Xavier Saelens, Ioanna Christopoulou, Claudia Soledad Sepúlveda, Florencia N. Linero, Luis Alberto Scolaro
Publikováno v:
Scientific Reports
SCIENTIFIC REPORTS
Scientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
SCIENTIFIC REPORTS
Scientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The syndrome viral haemorrhagic fever (VHF) designates a broad range of diseases that are caused by different viruses including members of the family Arenaviridae. Prophylaxis for Argentine Haemorrhagic Fever (AHF), caused by the arenavirus Junín (J
Publikováno v:
Archives of Environmental & Occupational Health. 70:256-264
This study sought to assess workplace violence in a Greek tertiary hospital for the first time. The authors conducted a descriptive study with 175 participants and examined the characteristics of violent episodes, the responses of victims and the adm
Publikováno v:
Vaccines
Volume 7
Issue 3
VACCINES
Vaccines, Vol 7, Iss 3, p 113 (2019)
Volume 7
Issue 3
VACCINES
Vaccines, Vol 7, Iss 3, p 113 (2019)
Background: Influenza virus infection predisposes to secondary bacterial pneumonia. Currently licensed influenza vaccines aim at the induction of neutralizing antibodies and are less effective if the induction of neutralizing antibodies is low and/or
Publikováno v:
Immunobiology. 216:1143-1147
Conjugate pneumococcal vaccines offer suboptimal protection against mucosal infections and are restricted in serotype and geographical coverage. New protein-based vaccines using conserved pneumococcal antigens and better mucosal adjuvant technology a
Influenza A virus is a pathogen that is feared for its capacity to cause pandemics. In this review, we illustrate the clinical evidence which support the theory that bacterial co-infection is a considerable risk factor for exacerbated disease during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02695995b212f58a131d4e880528b9b5
https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.957191
https://www.tandfonline.com/doi/abs/10.1586/14760584.2015.957191